IGC Pharma Inc. (IGC)
NYSE · Healthcare
IGC Pharma Inc. Long Term Debt 2011–2025
IGC Pharma Inc. annual long term debt history from 2015 to 2025. Long term debt refers to financial obligations that are due more than one year in the future.
- IGC Pharma Inc. long term debt as of March 31, 2025: 134,000, a 2.19% decrease year-over-year.
- IGC Pharma Inc. long term debt for 2025 were 134,000, a 2.19% decrease from 2024.
- IGC Pharma Inc. long term debt for 2024 were 137,000, a 2.84% decrease from 2023.
- IGC Pharma Inc. long term debt for 2023 were 141,000, a 2.08% decrease from 2022.
- IGC Pharma Inc. long term debt for 2022 were 144,000.
Long Term Debt
ANNUAL · $B
YEAR-OVER-YEAR GROWTH · %
| IGC Pharma Inc. Annual Long Term Debt (Millions of US $) | |
|---|---|
| 2025 | $0 |
| 2024 | $0 |
| 2023 | $0 |
| 2022 | $0 |
| 2021 | $0 |
| 2017 | $0 |
| 2016 | $1 |
| 2015 | $0 |
IGC Pharma Inc. Long Term Debt — FAQ
IGC Pharma Inc. (IGC) long term debt over the last 15 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see IGC's long term debt history?
The chart and table above show IGC Pharma Inc.'s long term debt by year and by quarter, including the growth rate.